Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Experimental Zika vaccine approved for human trials

The Food and Drug Administration approved an experimental Zika vaccine called GLS-5700 for a clinical trial in humans earlier today, the first such treatment to get an official nod from the agency. Initial trials will start with 40 healthy subjects getting dosed in the coming weeks, and if all goes without a hitch, preliminary results should be available later this year.

As Stat News points out, the thing to remember here is that this trial is meant to determine the vaccine's safety and proper dosage levels in humans. Assuming this first round yields valuable results, further trials will see the vaccine given to people actually infected with Zika. As such, there's really no telling how effective the vaccine currently is. So far though, creators Inovio and GeneOne say the experimental treatment has produced "robust antibody a T cell responses" in small and large animals -- a promising sign for its chances to combat Zika in humans.

The news comes just days after a CDC disclosure defined the scope of Zika-related birth defects in the US -- so far, three mothers have delivered babies with brain damage, while three others have terminated their pregnancies because of brain damage caused by the disease. The FDA also recently granted emergency approval to a Zika test produced by a Hologix, a Massachusetts-based pharmaceutical company. No Zika test has received full FDA approval, but this emergency approval gives laboratories the latitude to run the test if (or when) an official Zika outbreak occurs. This now means there are two tests -- the other comes from Quest Diagnostics -- available for use in critical situations where faster diagnoses could mean all the difference.


Source: https://www.engadget.com

0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies